EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • December 28th, 2006 • Ardea Biosciences, Inc./De • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is made and entered into effective as of December 21, 2006 (the “Effective Date”), by and between Intrabiotics Pharmaceuticals, Inc., (the “Company”), and Dr. Barry Quart (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • December 28th, 2006 • Ardea Biosciences, Inc./De • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is made and entered into effective as of December 21, 2006 (the “Effective Date”), by and between Intrabiotics Pharmaceuticals, Inc., (the “Company”), and Kimberly Manhard (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”.
Master Services AgreementMaster Services Agreement • December 28th, 2006 • Ardea Biosciences, Inc./De • Pharmaceutical preparations • California
This Master Services Agreement (the “Agreement”) is, entered into as of December 21, 2006 (the “Effective Date”) by and between IntraBiotics Pharmaceuticals, Inc. having a business address at 1009 Oak Hill Road, Suite 201, Lafayette, California 94549 (hereinafter referred to as “Company”) and Valeant Research & Development having a business address at 3300 Hyland Avenue, Costa Mesa, California 92626 (hereinafter referred to as “SPONSOR”).
NONCOMPETITION AGREEMENTNoncompetition Agreement • December 28th, 2006 • Ardea Biosciences, Inc./De • Pharmaceutical preparations • California
THIS NONCOMPETITION AGREEMENT (this “Noncompetition Agreement”) is being entered into as of December 21, 2006 (the “Effective Date”) by and between IntraBiotics Pharmaceuticals, Inc., a Delaware corporation (the “Purchaser”), and Valeant Research & Development, a Delaware corporation (the “Seller”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • December 28th, 2006 • Ardea Biosciences, Inc./De • Pharmaceutical preparations • California
This Asset Purchase Agreement (this Asset Purchase Agreement, together with all annexes, exhibits, schedules and other documents attached hereto, hereinafter referred to as the “Agreement”) dated as of December 21, 2006 is made by and among Valeant Research & Development, a Delaware corporation (“Seller”), Valeant Pharmaceuticals International, Inc., a Delaware corporation (“Parent”) (solely for purposes of Article 5) and IntraBiotics Pharmaceuticals, Inc., a Delaware corporation (“Purchaser”).
